Come up with a name for your new list and we'll add to it:
Signum Biosciences raised a round of funding on January 21, 2010. Investors include
Alzheimer's Drug Discovery Foundation.
Signum Biosciences is a biotechnology company dedicated to developing small-molecule therapeutics derived from the Signal Transduction Modulation (STM) platform to modulate signal transduction imbalan…